Page last updated: 2024-09-05

1-(5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride and Bacterial Disease

1-(5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride has been researched along with Bacterial Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, DK1
Choi, EC; Choi, KH; Hong, JS; Kim, SK; Lee, DK; Yoon, SJ1

Other Studies

2 other study(ies) available for 1-(5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride and Bacterial Disease

ArticleYear
Pharmacokinetic study of a new quinolone, DW-116.
    Drugs, 1995, Volume: 49 Suppl 2

    Topics: Animals; Anti-Infective Agents; Bacterial Infections; Dogs; Fluoroquinolones; Half-Life; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley

1995
In-vitro and in-vivo activities of DW-116, a new fluoroquinolone.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:4

    Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Dose-Response Relationship, Drug; Enterococcus faecalis; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Pseudomonas aeruginosa; Quinolones; Staphylococcus aureus

1997